摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3-dimethyl-6-phenylhexan-2-one | 1228310-14-2

中文名称
——
中文别名
——
英文名称
3,3-dimethyl-6-phenylhexan-2-one
英文别名
——
3,3-dimethyl-6-phenylhexan-2-one化学式
CAS
1228310-14-2
化学式
C14H20O
mdl
——
分子量
204.312
InChiKey
OMEIYLJJUWLDBY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,3-dimethyl-6-phenylhexan-2-one 作用下, 以 1,4-二氧六环 为溶剂, 以100%的产率得到1-bromo-3,3-dimethyl-6-phenylhexan-2-one
    参考文献:
    名称:
    Novel selective anti-androgens with a diphenylpentane skeleton
    摘要:
    We have proposed a multi-template approach for drug development, focusing on similar fold structures of proteins, and have effectively generated lead compounds for several drug targets. Modification of these polypharmacological lead compounds is then needed to generate target-selective compounds. In the work presented here, we aimed at separation of the anti-androgen activity and vitamin D activity of previously identified diphenylpentane lead compounds. Based on the determined X-ray crystal structures of androgen receptor and vitamin D receptor, bulky substituents were introduced at the t-butyl group in the lead compounds 2 and 3. As a result of this structural development, we obtained 16c, which exhibits more potent anti-androgen activity (IC(50): 0.13 mu M) than clinically used anti-androgen bicalutamide (IC(50): 0.67 mu M) with 30-fold selectivity over vitamin D activity. This result indicates that lead compounds obtained via the multi-template approach can indeed be structurally modified to generate target-selective compounds. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.09.011
  • 作为产物:
    描述:
    1-溴-3-苯基丙烷正丁基锂二异丙胺 作用下, 以 四氢呋喃 为溶剂, 反应 5.0h, 生成 3,3-dimethyl-6-phenylhexan-2-one
    参考文献:
    名称:
    镍 (0) - 催化末端丙二烯的氢氰化:支链烯丙腈的区域选择性和对映选择性方法
    摘要:
    本文报道了高度支化的区域选择性镍 (0) 催化的单取代和 1,1-二取代丙二烯的氢氰化以及 1,1-二取代丙二烯的不对称氢氰化,从而获得支化的叔和季 β,γ-烯丙基腈类。对于末端丙二烯的区域选择性氢氰化,镍 (0)/Biphephos 催化体系适用于包含酯、THP 基团、伯脂肪族碘化物和游离羧酸等官能团的底物范围,提供高达 96% 的产率。通过将基于 Ni(0)/TADDOL 的双亚磷酸酯催化剂应用于 1,1-二取代丙二烯的催化体系,支链季烯丙基腈的收率高达 99%,对映选择性高达 86%。这两种协议都利用了可管理的 HCN 源并证明了良好的原子经济性。此外,
    DOI:
    10.1002/adsc.202201189
点击查看最新优质反应信息

文献信息

  • PERFUME SYSTEMS
    申请人:The Procter & Gamble Company
    公开号:EP2362765A2
    公开(公告)日:2011-09-07
  • US8431520B2
    申请人:——
    公开号:US8431520B2
    公开(公告)日:2013-04-30
  • [EN] PERFUME SYSTEMS<br/>[FR] SYSTÈMES PARFUMEURS
    申请人:PROCTER & GAMBLE
    公开号:WO2010065446A2
    公开(公告)日:2010-06-10
    The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.
  • Novel selective anti-androgens with a diphenylpentane skeleton
    作者:Keisuke Maruyama、Tomomi Noguchi-Yachide、Kazuyuki Sugita、Yuichi Hashimoto、Minoru Ishikawa
    DOI:10.1016/j.bmcl.2010.09.011
    日期:2010.11
    We have proposed a multi-template approach for drug development, focusing on similar fold structures of proteins, and have effectively generated lead compounds for several drug targets. Modification of these polypharmacological lead compounds is then needed to generate target-selective compounds. In the work presented here, we aimed at separation of the anti-androgen activity and vitamin D activity of previously identified diphenylpentane lead compounds. Based on the determined X-ray crystal structures of androgen receptor and vitamin D receptor, bulky substituents were introduced at the t-butyl group in the lead compounds 2 and 3. As a result of this structural development, we obtained 16c, which exhibits more potent anti-androgen activity (IC(50): 0.13 mu M) than clinically used anti-androgen bicalutamide (IC(50): 0.67 mu M) with 30-fold selectivity over vitamin D activity. This result indicates that lead compounds obtained via the multi-template approach can indeed be structurally modified to generate target-selective compounds. (C) 2010 Elsevier Ltd. All rights reserved.
  • Nickel(0)‐Catalyzed Hydrocyanation of Terminal Allenes: A Regio‐ and Enantioselective Approach to Branched Allylic Nitriles
    作者:Timm Bury、Sven Kullmann、Bernhard Breit
    DOI:10.1002/adsc.202201189
    日期:2023.2.7
    A highly branched regioselective nickel(0)-catalyzed hydrocyanation of mono- and 1,1-disubstituted allenes as well as an asymmetric hydrocyanation of 1,1-disubstituted allenes are reported herein, giving access to branched tertiary and quaternary β,γ-allylic nitriles. For the regioselective hydrocyanation of terminal allenes, a nickel(0)/Biphephos catalytic system applicable to a substrate scope containing
    本文报道了高度支化的区域选择性镍 (0) 催化的单取代和 1,1-二取代丙二烯的氢氰化以及 1,1-二取代丙二烯的不对称氢氰化,从而获得支化的叔和季 β,γ-烯丙基腈类。对于末端丙二烯的区域选择性氢氰化,镍 (0)/Biphephos 催化体系适用于包含酯、THP 基团、伯脂肪族碘化物和游离羧酸等官能团的底物范围,提供高达 96% 的产率。通过将基于 Ni(0)/TADDOL 的双亚磷酸酯催化剂应用于 1,1-二取代丙二烯的催化体系,支链季烯丙基腈的收率高达 99%,对映选择性高达 86%。这两种协议都利用了可管理的 HCN 源并证明了良好的原子经济性。此外,
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐